Can genotype be used to tailor treatment of obesity? State of the art and guidelines for future studies and applications

Minerva Endocrinologica

Volumn 38, Issue 3, 2013, Pages 219-235

  Corella, D ^a,b   Ordovas J M ^c,d,e  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d IMDEA FOOD INSTITUTE   (Spain)

^e TUFTS UNIVERSITY   (United States)

Author keywords

Gene environment interactions; Genotype; Obesity

Indexed keywords

BODY WEIGHT; CLINICAL PRACTICE; DIET; EXERCISE; GENE ACTIVITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOME; GENOTYPE; HUMAN; METHODOLOGY; OBESITY; OBSERVATIONAL STUDY; PHENOTYPE; PRACTICE GUIDELINE; REVIEW;

CLINICAL TRIALS AS TOPIC; DIET, REDUCING; EXERCISE THERAPY; FORECASTING; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INDIVIDUALIZED MEDICINE; OBESITY; OBSERVATIONAL STUDY AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRACTICE GUIDELINES AS TOPIC; PROTEINS; RESEARCH DESIGN; TRANSCRIPTOME;

EID: 84890156675     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Temelkova-Kurktschiev T, Stefanov T. Lifestyle and genetics in obesity and type 2 diabetes. Exp Clin Endocrinol Diabetes 2012;120:1-6.
2. Demerath EW. The genetics of obesity in transition. Coll Antropol 2012;36:1161-8.
3. ENCODE Project Consortium, Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
4. Ginsburg GS. Realizing the opportunities of genomics in health care. JAMA 2013;309:1463-4.
5. Clarke L, Zheng-Bradley X, Smith R, Kulesha E, Xiao C, Toneva I et al. The 1000 Genomes Project: data management and community access. Nat Methods 2012;9:459-62.
6. Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab 2012;26:211-26.
7. Manco M, Dallapiccola B. Genetics of pediatric obesity. Pediatrics 2012;130:123-33.
8. Day FR, Loos RJ. Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics 2011;4:222-38.
9. Yu Z, Han S, Cao X, Zhu C, Wang X, Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring) 2012;20:396-406.
10. El-Sayed Moustafa JS, Froguel P. From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol 2013 [In press].
11. Blakemore AI, Froguel P. Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine. Ann N Y Acad Sci 2010;1214:180-9.
12. Heitmann BL, Westerterp KR, Loos RJ, Sørensen TI, O'Dea K, McLean P, et al. Obesity: lessons from evolution and the environment. Obes Rev 2012;13:910-22.
13. Hetherington MM, Cecil JE. Gene-environment interactions in obesity. Forum Nutr 2010;63:195-203.
14. Andreasen CH, Andersen G. Gene-environment interactions and obesity - further aspects of genomewide association studies. Nutrition 2009;25:998-1003.
15. Bouchard C. Gene-environment interactions in the etiology of obesity: defining the fundamentals. Obesity (Silver Spring) 2008;16(Suppl 3):S5-S10.
16. Brown J. Managing obesity in adults. Nurs Times 2012;108:18-9.
17. Yang N, Ginsburg GS, Simmons LA. Personalized medicine in women's obesity prevention and treatment: implications for research, policy and practice. Obes Rev 2013;14:145-61.
18. Fister K, Vuletic S, Kern J. Paving the way for personalised behaviourally based prevention of obesity: systematic search of the literature. Coll Antropol 2012;36(Suppl 1):201-10.
19. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res 2009;154:277-87.
20. Pasic MD, Samaan S, Yousef GM. Genomic medicine: new frontiers and new challenges. Clin Chem 2013,59:158-67.
21. Chadwell K. Clinical practice on the horizon: personalized medicine. Clin Nurse Spec 2013;27:36-43.
22. Tremblay J, Hamet P. Role of genomics on the path to personalized medicine. Metabolism 2013;62(Suppl 1):S2-5.
23. Keller MP, Attie AD. Physiological insights gained from gene expression analysis in obesity and diabetes. Annu Rev Nutr 2010;30:341-64.
24. Latham KE, Sapienza C, Engel N. The epigenetic lorax: gene-environment interactions in human health. Epigenomics 2012;4:383-402.
25. Slomko H, Heo HJ, Einstein FH. Minireview: Epigenetics of obesity and diabetes in humans. Endocrinology 2012;153:1025-30.
26. Xie B, Waters MJ, Schirra HJ. Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol 2012;2012:805683.
27. Stubbs J, Whybrow S, Teixeira P, Blundell J, Lawton C, Westenhoefer J et al. Problems in identifying predictors and correlates of weight loss and maintenance: implications for weight control therapies based on behaviour change. Obes Rev 2011;12:688-708.
28. Wirth A, Steinmetz B. Gender differences in changes in subcutaneous and intra-abdominal fat during weight reduction: an ultrasound study. Obes Res 1998;6:393-9. (Pubitemid 128679688)
29. Ara R, Blake L, Gray L, Hernandez M, Crowther M, Dunkley A et al. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A Systematic review. Health Technol Assess 2012;16:1-195.
30. Wadden TA, Neiberg RH, Wing RR, Clark JM, Delahanty LM, Hill JO et al. Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) 2011;19:1987-98.
31. Lovejoy JC, Sainsbury A; Stock Conference 2008 Working Group. Sex differences in obesity and the regulation of energy homeostasis. Obes Rev2009;10:154-67.
32. Shapira N. Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine. EPMA J 2013;4:1.
33. Morrison D, McLoone P, Brosnahan N, McCombie L, Smith A, Gordon J. A community pharmacy weight management programme: an evaluation of effectiveness. BMC Public Health 2013;13:282.
34. Hong T, Johnson C. A longitudinal analysis of adolescent smoking: using smoking status to differentiate the influence of body weight measures. J Sch Health 2013;83:314-21.
35. Shendure J, Lieberman Aiden E. The expanding scope of DNA sequencing. Nat Biotechnol 2012;30:1084-94.
36. Al-Gazali L. Genome-sequencing anniversary. Human genome sequencing: celebrating 10 years. Science 2011;331:873.
37. Mardis ER. Next-generation sequencing platforms. Annu Rev Anal Chem (Palo Alto Calif) 2013 [In press].
38. Levy-Sakin M, Ebenstein Y. Beyond sequencing: optical mapping of DNA in the age of nanotechnology and nanoscopy. Curr Opin Biotechnol 2013 [In press].
39. Bromberg Y. Chapter 15: disease gene prioritization. PLoS Comput Biol 2013;9:e1002902.
40. Wheeler E, Huang N, Bochukova EG, Keogh JM, Lindsay S, Garg S et al. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat Genet 2013;45:513-7.
41. Jarick I, Vogel CI, Scherag S, Schafer H, Hebebrand J, Hinney A et al. Novel common copy number variation for early onset extreme obesity on chromosome 11q11 identified by a genome-wide analysis. Hum Mol Genet 2011;20:840-52.
42. Yang TL, Guo Y, Shen H, Li J, Glessner JT, Qiu C et al. Copy number variation on chromosome 10q26.3 for obesity identified by a genome-wide study. J Clin Endocrinol Metab 2013;98:E191-5.
43. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010;363:166-76.
44. Fox CS, Heard-Costa N, Cupples LA, Dupuis J, Vasan RS, Atwood LD. Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project. BMC Med Genet 2007;8(Suppl 1):S18.
45. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889-94. (Pubitemid 46764279)
46. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008;40:768-75. (Pubitemid 351748863)
47. Wilier CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009;41:25-34.
48. Speliotes EK, Wilier CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937-48.
49. Bradfield JP, Taal HR, Timpson NJ, Scherag A, Lecoeur C, Warrington NM et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet 2012;44:526-31.
50. Fall T, Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol 2012,S0303-7207.
51. Berndt SI, Gustafsson S, Magi R, Ganna A, Wheeler E, Feitosa MF et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 2013;45:501-12.
52. Crossa J. From genotype x environment interaction to gene x environment interaction. Curr Genomics 2012;13:225-44.
53. Corella D, Ordovas JM. Integration of environment and disease into "omics" analysis. Curr Opin Mol Ther 2005;7:569-76. (Pubitemid 41763997)
54. Macinnis RJ, Hodge AM, Dixon HG, Peeters A, Johnson LE, English DR et al. Predictors of increased body weight and waist circumference for middle-aged adults. Public Health Nutr 2013:1-11.
55. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet 2004;5:71-118. (Pubitemid 39362742)
56. Gorman U, Mathers JC, Grimaldi KA, Ahlgren J, Nordstrom K. Do we know enough? A scientific and ethical analysis of the basis for genetic-based personalized nutrition. Genes Nutr 2013 [In press].
57. Phillips CM. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients 2013;5:32-57.
58. Corella D, Lai CQ, Demissie S, Cupples LA, Manning AK, Tucker KL et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med (Berl) 2007;85:119-28. (Pubitemid 46183611)
59. Corella D, Arnett DK, Tucker KL, Kabagambe EK, Tsai M, Parnell LD et al. A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J Nutr. 2011;141:2219-25.
60. Smith CE, Tucker KL, Yiannakouris N, Garcia-Bailo B, Mattei J, Lai CQ et al. Perilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits in hispanics of Caribbean origin. J Nutr 2008;138:1852-8.
61. Richardson K, Louie-Gao Q, Arnett DK, Parnell LD, Lai CQ, Davalos A et al. The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site. PLoS One 2011;6:e17944.
62. Zillikens MC, van Meurs JB, Rivadeneira F, Hofman A, Oostra BA, Sijbrands EJ et al. Interactions between dietary vitamin E intake and SIRT1 genetic variation influence body mass index. Am J Clin Nutr 2010,91:1387-93.
63. Junyent M, Parnell LD, Lai CQ, Arnett DK, Tsai MY, Kabagambe EK et al. ADAM17-i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study. Nutr Metab Cardiovasc Dis 2010;20:698-705.
64. Sonestedt E, Roos C, Gullberg B, Ericson U, Wirfält E, Orho-Melander M. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr 2009;90:1418-25.
65. Luan J, Browne PO, Harding AH, Halsall DJ, O'Rahilly S, Chatterjee VK et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 2001;50:686-9. (Pubitemid 32195237)
66. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 2003;12:2923-9. (Pubitemid 37442020)
67. Lamri A, Abi Khalil C, Jaziri R, Velho G, Lantieri O, Vol S et al. Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study. Int J Obes (Lond) 2012;36:218-24.
68. Phillips CM, Kesse-Guyot E, McManus R, Hercberg S, Lairon D, Planells R et al. High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults. J Nutr 2012;142:824-31.
69. Robitaille J, Brouillette C, Houde A, Lemieux S, Pérusse L, Tchernof A et al. Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet 2004;49:482-9. (Pubitemid 39314367)
70. Miyaki K, Sutani S, Kikuchi H, Takei I, Murata M, Watanabe K et al. Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy Japanese men. J Epidemiol 2005;15:203-10. (Pubitemid 41715785)
71. Li A, Meyre D. Challenges in reproducibility of genetic association studies: lessons learned from the obesity field. Int J Obes (Lond) 2013;37-67.
72. Corella D, Peloso G, Arnett DK, Demissie S, Cupples LA, Tucker K et al. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch Intern Med 2009;169:1897-906.
73. Corella D, Tai ES, Sorli JV, Chew SK, Coltell O, Sotos-Prieto M et al. Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction. Int J Obes (Lond) 2011;35:666-75.
74. Qi L, Corella D, Sorlí JV, Portolés O, Shen H, Coltell O et al. Genetic variation at the perilipin (PLIN) locus is associated with obesity-related phenotypes in White women. Clin Genet 2004;66:299-310. (Pubitemid 39317631)
75. Corella D, Qi L, Sorlí JV, Godoy D, Portolés O, Coltell O et al. Obese subjects carrying the 11482G>A polymorphism at the perilipin locus are resistant to weight loss after dietary energy restriction. J Clin Endocrinol Metab 2005;90:5121-6. (Pubitemid 41262263)
76. Corella D, Ordovas JM. Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet 2009;2:637-51.
77. Corella D, Ortega-Azorín C, Sorlí JV, Covas MI, Carrasco P, Salas-Salvado J et al. Statistical and biological gene-lifestyle interactions of MC4R and FTO with diet and physical activity on obesity: new effects on alcohol consumption. PLoS One 2012;7:e52344.
78. Kilpeläinen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 2011;8:e1001116.
79. Mitchell JA, Church TS, Rankinen T, Earnest CP, Sui X, Blair SN. FTO genotype and the weight loss benefits of moderate intensity exercise. Obesity (Silver Spring) 2010;18:641-3.
80. Rankinen T, Rice T, Teran-Garcia M, Rao DC, Bouchard C. FTO genotype is associated with exercise training-induced changes in body composition. Obesity (Silver Spring) 2010;18:322-6.
81. Grau K, Hansen T, Holst C, Astrup A, Saris WH, Arner P et al. Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes (Lond) 2009;33:1227-34.
82. Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM et al. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes 2012;61:3005-11.
83. Mattei J, Qi Q, Hu FB, Sacks FM, Qi L. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weightloss intervention. Am J Clin Nutr 2012;96:1129-36.
84. Heni M, Herzberg-Schafer S, Machicao F, Haring HU, Fritsche A. Dietary fiber intake modulates the association between variants in TCF7L2 and weight loss during a lifestyle intervention. Diabetes Care 2012;35:e24.
85. Haupt A, Thamer C, Heni M, Ketterer C, Machann J, Schick F et al. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes 2010;59:747-50.
86. Pan Q, Delahanty LM, Jablonski KA, Knowler WC, Kahn SE, Florez JC et al. Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program. Obesity (Silver Spring) 2013 [In press).
87. Zlatohlavek L, Vrablik M, Motykova E, Ceska R, Vasickova L, Dlouha D et al. FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention. Clin Biochem 2013;46:313-6.
88. Mirshahi UL, Still CD, Masker KK, Gerhard GS, Carey DJ, Mirshahi T. The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2011;96:E2088-96.
89. Valette M, Poitou C, Le Beyec J, Bouillot JL, Clement K, Czernichow S. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLoS One 2012;7:e48221.
90. Stocks T, Angquist L, Banasik K, Harder MN, Taylor MA, Hager J et al. TFAP2B influences the effect of dietary fat on weight loss under energy restriction. PLoS One 2012;7:e43212.
91. Larsen LH, Angquist L, Vimaleswaran KS, Hager J, Viguerie N, Loos RJ et al. Analyses of single nucleotide polymorphisms in selected nutrient-sensitive genes in weight-regain prevention: the DIOGENES study. Am J Clin Nutr 2012;95:1254-60.